[Correspondence] Perspective on proton beam therapy for oropharyngeal cancer | ClinicLens
The TORPEdO trial1 represents a landmark contribution to oropharyngeal cancer management, demonstrating similar late quality-of-life outcomes between intensity-modulated proton therapy (IMPT) and intensity-modulated radiotherapy (IMRT). However, as head and neck surgeons involved
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.